The tachykinin NK-1 receptor antagonist, RP-67580, infused into the ventral tegmental area prevents stress-induced analgesia in the formalin test

被引:22
|
作者
Altier, N [1 ]
Stewart, J [1 ]
机构
[1] Concordia Univ, Dept Psychol, Ctr Studies Behav Neurobiol, Montreal, PQ H3G 1M8, Canada
基金
英国医学研究理事会;
关键词
substance P; tachykinins; stress; tonic pain; formalin test; neurokinins; dopamine; antinociception;
D O I
10.1016/S0031-9384(98)00246-7
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Substance P (SP) receptors in the ventral tegmental area (VTA) play a critical role in mediating the stress-induced activation of midbrain ascending dopamine (DA) neurons. Interestingly, SP acting in the VTA induces analgesia in the formalin test for tonic pain. Because exposure to stress inhibits pain in this test, we speculated that SP receptors in the VTA might mediate stress-induced analgesia. The present study explored this idea by examining the effect of blocking tachykinin NK-1 receptors in the VTA on footshock stress-induced analgesia in the formalin test. Intra-VTA infusions of the novel tachykinin NK-1 receptor antagonist, RP-67580, prevented this response. This finding suggests that exposure to stress inhibits tonic pain through the release of endogenous SP in the VTA. (C) 1999 Elsevier Science Inc.
引用
收藏
页码:717 / 721
页数:5
相关论文
共 9 条
  • [1] RP-67580, A SPECIFIC TACHYKININ NK(1) RECEPTOR ANTAGONIST, RELIEVES CHRONIC HYPERALGESIA IN DIABETIC RATS
    COURTEIX, C
    LAVARENNE, J
    ESCHALIER, A
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 241 (2-3) : 267 - 270
  • [2] Opioid receptors in the ventral tegmental area contribute to stress-induced analgesia in the formalin test for tonic pain
    Altier, N
    Stewart, J
    [J]. BRAIN RESEARCH, 1996, 718 (1-2) : 203 - 206
  • [3] EFFECTS OF RP-67580, A TACHYKININ NK1 RECEPTOR ANTAGONIST, ON A PRIMARY AFFERENT-EVOKED RESPONSE OF VENTRAL ROOTS IN THE NEONATAL RAT SPINAL-CORD
    HOSOKI, R
    YANAGISAWA, M
    GUO, JZ
    YOSHIOKA, K
    MAEHARA, T
    OTSUKA, M
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1994, 113 (04) : 1141 - 1146
  • [4] RP67580, A NEUROKININ(1) RECEPTOR ANTAGONIST, DECREASED RESTRAINT STRESS-INDUCED DEFECATION IN RAT
    IKEDA, K
    MIYATA, K
    KUBOTA, H
    YAMADA, T
    TOMIOKA, K
    [J]. NEUROSCIENCE LETTERS, 1995, 198 (02) : 103 - 106
  • [5] EFFECTS OF THE TACHYKININ NK1 RECEPTOR ANTAGONIST, RP-67580, ON CENTRAL CARDIOVASCULAR AND BEHAVIORAL-EFFECTS OF SUBSTANCE-P, NEUROKININ-A AND NEUROKININ-B
    CULMAN, J
    WIEGAND, B
    SPITZNAGEL, H
    KLEE, S
    UNGER, T
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 (06) : 1310 - 1316
  • [6] NMDA RECEPTOR ANTAGONIST MK-801 BLOCKS NONOPIOID STRESS-INDUCED ANALGESIA IN THE FORMALIN TEST
    VACCARINO, AL
    MAREK, P
    STERNBERG, W
    LIEBESKIND, JC
    [J]. PAIN, 1992, 50 (01) : 119 - 123
  • [7] Stress-induced increase of cortical dopamine metabolism:: attenuation by a tachykinin NK1 receptor antagonist
    Hutson, PH
    Patel, S
    Jay, MT
    Barton, CL
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 484 (01) : 57 - 64
  • [8] Morphine, the NMDA receptor antagonist MK801 and the tachykinin NK1 receptor antagonist RP67580 attenuate the development of inflammation-induced progressive tactile hypersensitivity
    Ma, QP
    Allchorne, AJ
    Woolf, CJ
    [J]. PAIN, 1998, 77 (01) : 49 - 57
  • [9] The tachykinin NK1 receptor antagonist, RP67580, inhibits the bradykinin-induced rise in intracellular Ca2+ concentration in bovine pulmonary artery endothelial cells
    Westra-De Vlieger, JF
    Van den Wijngaard, PWJ
    Koster, AS
    Wilting, J
    Leysen, J
    Van Heuven-Nolsen, D
    Nijkamp, FP
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 342 (2-3) : 359 - 366